ethyl pyruvate has been researched along with Chest Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dieteren, S; Franz, N; Marzi, I; Mörs, K; Perl, M; Relja, B; Schmidt, J; Wagner, N | 1 |
Dieteren, S; Franz, N; Köhler, K; Marzi, I; Mörs, K; Nicin, L; Perl, M; Relja, B; Schmidt, J; Wagner, N | 1 |
2 other study(ies) available for ethyl pyruvate and Chest Injuries
Article | Year |
---|---|
Ethyl pyruvate reduces acute lung damage following trauma and hemorrhagic shock via inhibition of NF-κB and HMGB1.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Gene Expression Regulation; HMGB1 Protein; Humans; Lung; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Rats; Rats, Inbred Lew; Shock, Hemorrhagic; Signal Transduction; Thoracic Injuries; Tumor Necrosis Factor-alpha | 2018 |
Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release.
Topics: Animals; Female; HMGB1 Protein; Inflammation; Liver; NF-kappa B; Pyruvates; Rats; Rats, Inbred Lew; Shock, Hemorrhagic; Thoracic Injuries; Wounds, Nonpenetrating | 2018 |